You are here
Supply of Ordine (morphine) to cease
The supply of Ordine (morphine) oral liquid will be discontinued in Australia between November 2023 and early 2024.
Ordine is used to manage severe pain and difficult or laboured breathing in many care settings, including cancer treatment and end-of-life care.
If you or someone you care for takes Ordine oral liquid and you have concerns about ongoing treatment with this medicine, we recommend you talk to your prescriber.
While Ordine oral liquids are still available from pharmacies, all remaining supplies are expected to be depleted by late May 2024. Overseas-registered morphine oral liquids will be available from 1 December 2023 and you can talk to your pharmacist or prescriber about whether one of these is suitable for you.
There are other oral liquid pain relievers available in Australia and your prescriber is best placed to provide advice about ongoing treatment options.
Health professionals should identify patients currently taking Ordine oral liquid to discuss the implications of this discontinuation on their treatment plan. Clinical advice and information on accessing alternatives can be found on our About the discontinuation of Ordine (morphine) oral liquid page.